|
ZNF8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.606300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.665200E-01 |
| Normal-vs-Stage2 |
2.830000E-02 |
| Normal-vs-Stage3 |
1.985710E-02 |
| Normal-vs-Stage4 |
5.192000E-02 |
| Stage1-vs-Stage2 |
1.495000E-01 |
| Stage1-vs-Stage3 |
9.484000E-02 |
| Stage1-vs-Stage4 |
2.388800E-01 |
| Stage2-vs-Stage3 |
8.319200E-01 |
| Stage2-vs-Stage4 |
6.220200E-01 |
| Stage3-vs-Stage4 |
7.449800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.367800E-01 |
| Normal-vs-AfricanAmerican |
9.492600E-01 |
| Normal-vs-Asian |
1.540420E-01 |
| Caucasian-vs-AfricanAmerican |
2.672400E-01 |
| Caucasian-vs-Asian |
8.178200E-01 |
| AfricanAmerican-vs-Asian |
2.483400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.275700E-02 |
| Normal-vs-Female |
1.012440E-01 |
| Male-vs-Female |
6.439400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.354000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.078400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.089520E-02 |
| Normal-vs-Age(81-100Yrs) |
6.894200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.385200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.043900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.005800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.388000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.064400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.356200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.949700E-02 |
| Classical-VS-Follicular |
1.58925000000032E-05 |
| Classical-VS-Other |
2.366800E-01 |
| Classical-VS-Normal |
5.638000E-01 |
| Tall-VS-Follicular |
2.125600E-01 |
| Tall-VS-Other |
7.326400E-01 |
| Tall-VS-Normal |
3.968100E-02 |
| Follicular-VS-Other |
7.781400E-01 |
| Follicular-VS-Normal |
4.197700E-04 |
| Other-VS-Normal |
1.544580E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.985600E-02 |
| Normal-vs-N1 |
1.099150E-01 |
| N0-vs-N1 |
7.973200E-01 |
|
|
